Trial Profile
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 15 Aug 2014 New trial record
- 21 Jan 2010
- 16 Nov 2009